Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrea Eisen, MD
Sunnybrook Health Sciences Centre
Principal Investigator - Ian Dayes, MD
Juravinski Hospital and Cancer Centre
Principal Investigator - Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Study Director - Ralph George, MD
St. Michael's Hospital, CIBC Breast Centre
Principal Investigator - Ur Metser, MD
Princess Margaret Hospital, Canada
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre
Ottawa, Ontario, Canada
- Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Sunnybrook Odette Cancer Centre
Toronto, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Dec 2016
- Primary completion
- 31 Mar 2023
- Completion
- 31 Mar 2023
- Last update posted
- 19 Jan 2024
- Registered enrollment
- 369
- Registry id
- NCT02751710
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.